Blood transfusion : current debates

被引:0
作者
Andreu, Georges [1 ]
Boiron, Jean-Michel [2 ]
Garraud, Olivier [3 ]
Lefrere, Jean-Jacques [4 ,5 ]
机构
[1] Inst Natl Transfus Sanguine, F-75015 Paris, France
[2] ETS Aquitaine Limousin, Etab Franccais Sang Aquitaine, PA Raba Leon, F-33076 Bordeaux, France
[3] Etab Francais Sang Auvergne Loire, F-42023 St Etienne 2, France
[4] Inst Natl Transfus Sanguine, F-75015 Paris, France
[5] Univ Jules Verne, Ctr Hosp Univ, Amiens, France
来源
HEMATOLOGIE | 2008年 / 14卷 / 01期
关键词
transfusion safety; cellular products; prevention of risks; transfusion; blood donations;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The present debate in transfusion deals with the following issues: triggers of the transfusion of packed red cell concentrates; cellular product storage in the indications of phenotyped packed-red cells; consequences of the implementation of hemoglobin testing before and after blood donations; ex vivo generation of human red blood cells; management of transfused patients having a platelet refractoriness; pooled platelet concentrates and apheresis platelet concentrates in transfusion strategies; triggers in prophylactic transfusion of platelets; prophylactic transfusion of high doses of platelets in patients after intensive chemotherapy; pathogen inactivation procedures during the preparation of cellular products; deferral from blood donation of individuals transfused with cellular products and of men having had sex with men; indications of various therapeutic plasma preparations; detection of anti-HLA antibodies in transfusion practice; measures to prevent the transfusion-related acute lung injury (TRALI); and transfusion education in France.
引用
收藏
页码:65 / 89
页数:25
相关论文
共 103 条
[1]   Economic consequences of alterations in platelet transfusion dose: analysis of a prospective, randomized, double-blind trial [J].
Ackerman, SJ ;
Klumpp, TR ;
Guzman, GI ;
Herman, JH ;
Gaughan, JP ;
Bleecker, GC ;
Mangan, KF .
TRANSFUSION, 2000, 40 (12) :1457-1462
[2]   Clinical effect of buffy-coat vs. apheresis platelet concentrates in patients with severe thrombocytopenia after intensive chemotherapy [J].
Akkok, C. A. ;
Brinch, L. ;
Lauritzsen, G. F. ;
Solheim, B. G. ;
Kjeldsen-Kragh, J. .
VOX SANGUINIS, 2007, 93 (01) :42-48
[3]  
Andreu G, 2002, TRANSFUSION
[4]   Introduction of platelet additive solutions in transfusion practice -: Advantages, disadvantages and benefit for patients [J].
Andreu, Georges ;
Vasse, Julie ;
Herve, Francoise ;
Tardivel, Rene .
TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2007, 14 (01) :100-106
[5]  
[Anonymous], 2002, TRANSFUSION GLOBULES
[6]  
[Anonymous], 2004, EVALUATION RISQUE VM
[7]  
[Anonymous], 1998, INDICATIONS INDICATI
[8]  
[Anonymous], 2000, ANAL RISQUE TRANSMIS
[9]   In vivo recovery and survival of apheresis and whole blood-derived platelets: a paired comparison in healthy volunteers [J].
Arnold, DM ;
Heddle, NM ;
Kulczycky, M ;
Carruthers, J ;
Sigouin, C ;
Blajchman, MA .
TRANSFUSION, 2006, 46 (02) :257-264
[10]  
Beck KH, 2000, INFUS THER TRANSFUS, V27, P144